Mach, François

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 4,854

Statins as a newly recognized type of immunomodulator.

Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine

Atherosclerosis and Cardiovascular DiseasesImmunotherapy and Immune Responses

Cited by 1,383